- Pro to the question "Should Prescription Drugs Be Advertised Directly to Consumers?"
“An important benefit of direct to consumer (DTC) advertising is that it fosters an informed conversation about health, disease and treatments between patients and their health care practitioners.
A strong empirical record demonstrates that DTC communications about prescription medicines serve the public health by:
Increasing awareness about diseases;
Educating patients about treatment options;
Motivating patients to contact their physicians and engage in a dialogue about health concerns;
Increasing the likelihood that patients will receive appropriate care for conditions that are frequently under-diagnosed and under-treated; and
Encouraging compliance with prescription drug treatment regimens…
PhRMA members want patients and consumers to talk to their physicians about the medicines that may help them and to fully understand the known risks regarding these medicines. We know that DTC communications, particularly DTC television advertising, can be a powerful tool for reaching and educating millions of people.”
“PhRMA Guiding Principles: Direct to Consumer Advertisements About Prescription Medicines,” phrma.org, Dec. 2008
“The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.”
“About PhRMA,” phrma.org (accessed Mar. 24, 2010)
“PhRMA’s mission is winning advocacy for public policies that encourage the discovery of life-saving and life enhancing new medicines for patients by pharmaceutical/biotechnology research companies.
To accomplish this mission, PhRMA is dedicated to achieving in Washington, D.C., the states and the world: 1. Broad patient access to safe and effective medicines through a free market, without price controls; 2. Strong intellectual property incentives, and; 3. Transparent, efficient regulation and a free flow of information to patients.”
“Mission Statement,” phrma.org (accessed Mar. 24, 2010)
- 501 (c)(6) membership organization
- Quoted in:
- Pro & Con Quotes: Should Prescription Drugs Be Advertised Directly to Consumers?